|
The Journal of Lipid Research, Vol. 39, 884-891, April 1998
Copyright © 1998 by Lipid Research, Inc.
Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period
Jumana Saleha,
Lucinda K. M. Summersb,
Katherine Cianflonea,
Barbara A. Fieldingb,
Allan D. Snidermana, and
Keith N. Fraynb
a McGill Unit for the Prevention of Cardiovascular Diseases, Royal Victoria Hospital, Montreal, Quebec, Canada
b Oxford Lipid Metabolism Group, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford OX2 6HE, UK
Correspondence to:
Katherine Cianflone.
The objective of this study was to determine whether Acylation Stimulating Protein (ASP) is generated in vivo by human adipose tissue during the postprandial period. After a fat meal, samples from 12 subjects were obtained (up to 6 h) from an arterialized hand vein and an anterior abdominal wall vein that drains adipose tissue. Veno-arterial (V-A) gradients across the subcutaneous adipose tissue bed were calculated. The data demonstrate that ASP is produced in vivo (positive V-A gradient) with maximal production at 35 h postprandially. The plasma triacylglycerol (TAG) clearance was evidenced by a negative V-A gradient. It increased substantially after 3 h and remained prominant until the final time point. There was, therefore, a close temporal coordination between ASP generation and TAG clearance. In contrast, plasma insulin and non-esterified fatty acid (NEFA) had an early (12 h) postprandial change. Fatty acid incorporation into adipose tissue (FIAT) was calculated from V-A glycerol and non-esterified fatty acid (NEFA) differences postprandially. FIAT was negative during the first hour, implying net fat mobilization. FIAT then became increasingly positive, implying net fat deposition, and overall followed the same time course as ASP and TAG clearance. There was a direct positive correlation between total ASP production and total FIAT (r = 0.566, P < 0.05).
These data demonstrate that ASP is generated in vivo by human adipocytes and that this process is accentuated postprandially, supporting the concept that ASP plays an important role in clearance of TAG from plasma and fatty acid storage in adipose tissue.Saleh, J., L. K. M. Summers, K. Cianflone, B. A. Fielding, A. D. Sniderman, and K. N. Frayn. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J. Lipid Res. 1998. 39: 884891.
Supplementary key words:
complement 3A, adipose tissue, human, postprandial lipemia

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Paglialunga, P. Julien, Y. Tahiri, F. Cadelis, J. Bergeron, D. Gaudet, and K. Cianflone
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels
J. Lipid Res.,
June 1, 2009;
50(6):
1109 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Saleh, M. Al-Khanbashi, M. Al-Maarof, M. Al-Lawati, S. G Rizvi, and K. Cianflone
Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle
Eur. J. Endocrinol.,
February 1, 2009;
160(2):
301 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. F. Wamba, J. Mi, X.-Y. Zhao, M.-X. Zhang, Y. Wen, H. Cheng, D.-Q. Hou, and K. Cianflone
Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents
Eur. J. Endocrinol.,
December 1, 2008;
159(6):
781 - 790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paglialunga, A. Fisette, Y. Yan, Y. Deshaies, J.-F. Brouillette, M. Pekna, and K. Cianflone
Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice
Am J Physiol Endocrinol Metab,
March 1, 2008;
294(3):
E521 - E529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cui, S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone
Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo
Am J Physiol Endocrinol Metab,
December 1, 2007;
293(6):
E1482 - E1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Goralski, T. C. McCarthy, E. A. Hanniman, B. A. Zabel, E. C. Butcher, S. D. Parlee, S. Muruganandan, and C. J. Sinal
Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism
J. Biol. Chem.,
September 21, 2007;
282(38):
28175 - 28188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj, G. Beauregard, E. Loizon, M. Moldes, K. Clement, Y. Tahiri, K. Cianflone, H. Vidal, and R. Rabasa-Lhoret
Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin.
J. Endocrinol.,
November 1, 2006;
191(2):
427 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maslowska, H. Legakis, F. Assadi, and K. Cianflone
Targeting the signaling pathway of acylation stimulating protein
J. Lipid Res.,
March 1, 2006;
47(3):
643 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj and K. Cianflone
Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP
Am J Physiol Endocrinol Metab,
July 1, 2004;
287(1):
E150 - E159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj, A. D. Sniderman, and K. Cianflone
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes
J. Lipid Res.,
April 1, 2004;
45(4):
657 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J van Oostrom, H. van Dijk, C. Verseyden, A. D Sniderman, K. Cianflone, T. J Rabelink, and M. Castro Cabezas
Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3
Am. J. Clinical Nutrition,
March 1, 2004;
79(3):
510 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xia, K. L. Stanhope, E. Digitale, O.-M. Simion, L. Chen, P. Havel, and K. Cianflone
Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice
J. Biol. Chem.,
February 6, 2004;
279(6):
4051 - 4057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Havel
Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism
Diabetes,
February 1, 2004;
53(90001):
S143 - 151.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Cianflone, R. Zakarian, C. Couillard, B. Delplanque, J.-P. Despres, and A. Sniderman
Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance
J. Lipid Res.,
January 1, 2004;
45(1):
124 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas
Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia
J. Lipid Res.,
November 1, 2003;
44(11):
2100 - 2108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj, P. J. Havel, S. Phelis, D. Blank, A. D. Sniderman, and K. Cianflone
Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1594 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xia, A. D. Sniderman, and K. Cianflone
Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice
J. Biol. Chem.,
November 22, 2002;
277(48):
45874 - 45879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meijssen, H. van Dijk, C. Verseyden, D.W. Erkelens, and M. C. Cabezas
Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2002;
22(5):
811 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meijssen, R. J. Derksen, S. Bilecen, D. W. Erkelens, and M. C. Cabezas
In Vivo Modulation of Plasma Free Fatty Acids in Patients with Familial Combined Hyperlipidemia Using Lipid-Lowering Medication
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1576 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Matthan, K. Cianflone, A. H. Lichtenstein, L. M. Ausman, M. Jauhiainen, and P. J. H. Jones
Hydrogenated fat consumption affects acylation- stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women
J. Lipid Res.,
November 1, 2001;
42(11):
1841 - 1848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.J.M. Halkes, H. van Dijk, P.P.T. de Jaegere, H.W.M. Plokker, Y. van der Helm, D. W. Erkelens, and M. Castro Cabezas
Postprandial Increase of Complement Component 3 in Normolipidemic Patients With Coronary Artery Disease: Effects of Expanded-Dose Simvastatin
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2001;
21(9):
1526 - 1530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Koistinen, H. Vidal, S.-L. Karonen, E. Dusserre, P. Vallier, V. A. Koivisto, and P. Ebeling
Plasma Acylation Stimulating Protein Concentration and Subcutaneous Adipose Tissue C3 mRNA Expression in Nondiabetic and Type 2 Diabetic Men
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2001;
21(6):
1034 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ylitalo, P. Pajukanta, S. Meri, R. M. Cantor, N. Mero-Matikainen, J. Vakkilainen, I. Nuotio, and M.-R. Taskinen
Serum C3 but Not Plasma Acylation-Stimulating Protein Is Elevated in Finnish Patients With Familial Combined Hyperlipidemia
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2001;
21(5):
838 - 843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj, P. Jones, A. D. Sniderman, and K. Cianflone
Enhanced dietary fat clearance in postobese women
J. Lipid Res.,
April 1, 2001;
42(4):
571 - 580.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Kalant, S. Phélis, B. A. Fielding, K. N. Frayn, K. Cianflone, and A. D. Sniderman
Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women
J. Lipid Res.,
December 1, 2000;
41(12):
1963 - 1968.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Imbeault, C. Couillard, A. Tremblay, J-P. Després, and P. Mauriège
Reduced {alpha}2-adrenergic sensitivity of subcutaneous abdominal adipocytes as a modulator of fasting and postprandial triglyceride levels in men
J. Lipid Res.,
September 1, 2000;
41(9):
1367 - 1375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Murray, P. J. Havel, A. D. Sniderman, and K. Cianflone
Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein
Endocrinology,
March 1, 2000;
141(3):
1041 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone
Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice
J. Biol. Chem.,
December 17, 1999;
274(51):
36219 - 36225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Murray, A. D. Sniderman, and K. Cianflone
Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance
J. Lipid Res.,
September 1, 1999;
40(9):
1671 - 1676.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Murray, A. D. Sniderman, and K. Cianflone
Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice
Am J Physiol Endocrinol Metab,
September 1, 1999;
277(3):
E474 - E480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Van Harmelen, S. Reynisdottir, K. Cianflone, E. Degerman, J. Hoffstedt, K. Nilsell, A. Sniderman, and P. Arner
Mechanisms Involved in the Regulation of Free Fatty Acid Release from Isolated Human Fat Cells by Acylation-stimulating Protein and Insulin
J. Biol. Chem.,
June 25, 1999;
274(26):
18243 - 18251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Saleh, N. Christou, and K. Cianflone
Regional specificity of ASP binding in human adipose tissue
Am J Physiol Endocrinol Metab,
May 1, 1999;
276(5):
E815 - E821.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|